Pg. Wells et al., OXIDATIVE DAMAGE IN CHEMICAL TERATOGENESIS, Mutation research. Fundamental and molecular mechanisms of mutagenesis, 396(1-2), 1997, pp. 65-78
Citations number
57
Journal title
Mutation research. Fundamental and molecular mechanisms of mutagenesis
The teratogenicity of many xenobiotics is thought to depend at least i
n part upon their bioactivation by embryonic cytochromes P450, prostag
landin ii synthase (PHS) and lipoxygenases (LPOs) to electrophilic and
/or free radical reactive intermediates that covalently bind to or oxi
dize cellular macromolecules such as DNA, protein and lipid, resulting
in in utero death or teratogenesis. Using as models the tobacco carci
nogens benzo[ a]pyrene (B[a]P) and 4-(methylnitrosamino)-1-(3-pyridyl)
-1-butanone (NNK), the anticonvulsant drug phenytoin, structurally rel
ated anticonvulsants (e.g. mephenytoin, nirvanol, trimethadione, dimet
hadione) and the sedative drug thalidomide, we have examined the poten
tial teratologic relevance of free radical-initiated, reactive oxygen
species (ROS)-mediated oxidative molecular target damage, genotoxicity
(micronucleus formation) and DNA repair in mouse and rabbit models in
vivo and in embryo culture, and in vitro using purified enzymes or cu
ltured rat skin fibroblasts. These teratogens were bioactivated by PHS
and LPOs to free radical reactive intermediary metabolites, character
ized by electron spin resonance spectrometry, that initiated ROS forma
tion, including hydroxyl radicals, which were characterized by salicyl
ate hydroxylation. ROS-initiated oxidation of DNA (8-hydroxy-2'-deoxyg
uanosine formation), protein (carbonyl formation), glutathione (GSH) a
nd lipid (peroxidation), and embryotoxicity were shown for phenytoin,
its major hydroxylated metabolite 5-( p-hydroxyphenyl)-5-phenylhydanto
in (HPPH), thalidomide, B[a]P and NNK in vivo and/or in embryo culture
, the latter indicating a teratologically critical role for embryonic,
as distinct from maternal, processes. DNA oxidation and teratogenicit
y of phenytoin and thalidomide were reduced by PI-IS inhibitors. Oxida
tive macromolecular lesions and teratogenicity also were reduced by th
e free radical trapping agent phenylbutylnitrone (PEN), and the antiox
idants caffeic acid and vitamin E. In embryo culture, addition of supe
roxide dismutase (SOD) to the medium enhanced embryonic SOD activity,
and SOD or catalase blocked the oxidative lesions and embryotoxicity i
nitiated by phenytoin and B[a]P, suggesting a major contribution of RO
S, as distinct from covalent binding, to the teratologic mechanism. In
in vivo studies, other antioxidative enzymes like GSH peroxidase, GSH
reductase and glucose-6-phosphate dehydrogenase (G6PD) were similarly
protective. Even untreated G6PD-deficient mice had enhanced embryopat
hies, indicating a teratological role for endogenous oxidative stress.
In cultured fibroblasts, B[a]P, NNK, phenytoin and HPPH initiated DNA
oxidation and micronucleus formation, which were inhibited by SOD. Ox
idation of DNA may be particularly critical, since transgenic mice wit
h +/- or -/- deficiencies in the p53 tumor suppressor gene, which faci
litates DNA repair, are more susceptible to phenytoin and B[a]P terato
genicity. Even p53-deficient mice treated only with normal saline show
ed enhanced embryopathies, suggesting the teratological importance of
endogenous oxidative stress, as observed with G6PD deficiency. These r
esults suggest that oxidative macromolecular damage may play a role in
the teratologic mechanism of xenobiotics that are bioactivated to a r
eactive intermediate, as well in the mechanism of embryopathies occurr
ing in the absence of xenobiotic exposure, (C) 1997 Elsevier Science B
.V.